Senior Director
GlaxoSmithKline
Valeriu Damian is leading the Systems Modeling and Translational Biology group in GlaxoSmithKline. The group is responsible for providing translational modeling support for all therapeutic areas in GSK. This includes Physiological Based PK (PBPK), PK/PD, Quantitative Systems Pharmacology and Toxicology (QSP/T) modeling for all modalities and delivery routes. Valeriu holds a PhD in computer science from University of Iowa and a computer engineering diploma from Politehnica University of Bucharest in Romania. Throughout his 23 years carrier in GSK Valeriu focus has been on integrating diverse scientific ideas from multiple disciplines – mathematics, informatics, chemistry, physics, biology and engineering – into mechanistically based models and demonstrated their capability to interpret available data, to enhance understanding, to suggest testable hypotheses, to push the scientific boundaries and ultimately to bring better, faster and more affordable medication to the patients. Valeriu made significant contributions to PBPK modeling of inhaled, transdermal, ocular and long acting injectable delivery as well as QSP model development. In 2018 Valeriu was the chair for the QSP Special Interest Group in ISoP.
Disclosure information not submitted.
Thursday, January 13, 2022
12:30 PM – 1:30 PM ET
.png)